SL
SVB Leerink Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
76
Madrigal Pharmaceuticals
MDGL
$9.65B
|
MK
Mike Kratky
| $432.89 | $315 |
27%
downside
| Outperform | 2 years ago |
|
77
Roivant Sciences
ROIV
$8.82B
|
DR
David Risinger
| $12.92 | $10 |
23%
downside
| Outperform | 2 years ago |
|
78
Eli Lilly
LLY
$652B
|
DR
David Risinger
| $727.21 | $410 |
44%
downside
| Outperform | 2 years ago |
|
79
HCA Healthcare
HCA
$98.5B
|
WM
Whit Mayo
| $420.77 | $286 |
32%
downside
| Outperform | 2 years ago |
|
80
Vaxcyte
PCVX
$4.29B
|
DR
David Risinger
| $33.02 | $60 |
82%
upside
| Outperform | 2 years ago |
|
81
Kymera Therapeutics
KYMR
$3.11B
|
MK
Mike Kratky
| $43.51 | $31 |
29%
downside
| Market Perform | 2 years ago |
|
82
Wave Life Sciences
WVE
$1.32B
|
MF
Mani Foroohar
| $8.29 | $7 |
16%
downside
| Market Perform | 2 years ago |
|
83
Nurix Therapeutics
NRIX
$758M
|
AB
Andrew Berens
| $9.91 | $28 |
183%
upside
| Outperform | 2 years ago |
|
84
ARS Pharmaceuticals
SPRY
$995M
|
RR
Roanna Ruiz
| $10.07 | $14 |
39%
upside
| Outperform | 2 years ago |
|
85
Replimune Group
REPL
$494M
|
JC
Jonathan Chang
| $6.33 | $34 |
437%
upside
| Outperform | 2 years ago |
|
86
Gossamer Bio
GOSS
$668M
|
JS
Joseph Schwartz
| $2.94 | $10 |
240%
upside
| Outperform | 2 years ago |
|
87
Veeva Systems
VEEV
$44.7B
|
SD
Stephanie Davis
| $272.93 | $233 |
15%
downside
| Outperform | 2 years ago |
|
88
Axsome Therapeutics
AXSM
$6.25B
|
MG
Marc Goodman
| $125.17 | $85 |
32%
downside
| Outperform | 2 years ago |
|
89
Arvinas
ARVN
$575M
|
AB
Andrew Berens
| $7.83 | $70 |
794%
upside
| Outperform | 2 years ago |
|
90
Trevi Therapeutics
TRVI
$854M
|
TS
Thomas Smith
| $7.01 | $6 |
14%
downside
| Outperform | 2 years ago |
|
91
Surgery Partners
SGRY
$2.89B
|
WM
Whit Mayo
| $22.51 | $40 |
78%
upside
| Outperform | 2 years ago |
|
92
Twist Bioscience
TWST
$1.55B
|
PS
Puneet Souda
| $25.76 | $30 |
16%
upside
| Market Perform | 2 years ago |
|
93
Theravance Biopharma
TBPH
$703M
|
DR
David Risinger
| $13.95 | $14 |
0%
upside
| Outperform | 2 years ago |
|
94
Lantheus
LNTH
$3.72B
|
RR
Roanna Ruiz
| $54.75 | $120 |
119%
upside
| Outperform | 2 years ago |
|
95
Abeona Therapeutics
ABEO
$353M
|
MF
Mani Foroohar
| $6.89 | $6 |
13%
downside
| Market Perform | 2 years ago |
|
96
AstraZeneca
AZN
$253B
|
AB
Andrew Berens
| $81.70 | $79 |
3%
downside
| Outperform | 2 years ago |
|
97
AirSculpt Technologies
AIRS
$367M
|
WM
Whit Mayo
| $5.88 | $8 |
36%
upside
| Outperform | 2 years ago |
|
98
Privia Health
PRVA
$2.86B
|
WM
Whit Mayo
| $23.28 | $39 |
68%
upside
| Outperform | 2 years ago |
|
99
Solid Biosciences
SLDB
$428M
|
JS
Joseph Schwartz
| $5.50 | $6 |
9%
upside
| Market Perform | 2 years ago |
|
100
AdaptHealth
AHCO
$1.29B
|
WM
Whit Mayo
| $9.51 | $30 |
215%
upside
| Outperform | 2 years ago |
|